An association of medical practitioners in Maharashtra Friday urged the government to utilise homoeopathy to combat the swine flu epidemic that has gripped many parts of India.
The H1N1 virus has already claimed around 700 lives in the country, including 10 in Maharashtra. A total of 182 more cases have been reported in the state.
Anwar Amir of the Maharashtra University of Health Science and secretary-general of the Homoeopathic Post-Graduate Association (HPGA) said many states were under siege with a high mortality rate of H1N1 cases at around seven percent.
"Unfortunately, there is no vaccine in the market, any form of preventative or curative treatment available in allopathy. This has created lot of apprehensions among the people, but homoeopathy has an effective treatment," Amir told a media gathering.
Detailing the record of homoeopathic treatment including during the Spanish flu of 1918 that affected around 50 million people globally, he said homoeopathy had brought down the mortality rate from a staggering 30 percent to 1.05 percent with proper use of Genus Epidemicus.
He said the Genus Epidemicus homoeopathic remedies include medicines like Aconite, Arsenic Alb and Aviaire which were effective also for the current swine flu epidemic based on its presentation from the beginning to the last stage of the disease.
"We have already written to the union health ministry, Maharashtra health ministry, director-general of health services and other authorities, stressing the need to include homoeopathic preventive and curative medicines in the treatment regime. At the rate at which the disease is spreading, we cannot afford to lower our guard," Amir said.
Other homoeopaths like Kishore Mehta, P.P. Page, Swati Bhagwat, Sanjeev Dole and Satish Gala also spoke about various facets of the disease.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
